{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T05:16:36Z","timestamp":1721538996849},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00066-009-1958-z","type":"journal-article","created":{"date-parts":[[2009,6,8]],"date-time":"2009-06-08T10:42:54Z","timestamp":1244457774000},"page":"349-354","source":"Crossref","is-referenced-by-count":9,"title":["What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?"],"prefix":"10.1007","volume":"185","author":[{"given":"Johannes","family":"Cla\u00dfen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Schmidberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Souchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Weissbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg T.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bamberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,9]]},"reference":[{"key":"1958_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.eururo.2005.06.019","volume":"48","author":"P. Albers","year":"2005","unstructured":"Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer. Eur Urol 2005;48:885\u201394.","journal-title":"Eur Urol"},{"key":"1958_CR2","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","volume":"23","author":"J. Aparicio","year":"2005","unstructured":"Aparicio J, Germ\u00e0 JR, del Muro XG, et al. Risk-adapted management for patients with clinical stage I seminoma: the second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 2005;23:8717\u201323.","journal-title":"J Clin Oncol"},{"key":"1958_CR3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<823::AID-IJC22>3.0.CO;2-V","volume":"83","author":"M. Bamberg","year":"1999","unstructured":"Bamberg M, Schmidberger H, Meisner C, et al. Radiotherapy for stage I, IIA\/B testicular seminoma. Int J Cancer 1999;83:823\u20137.","journal-title":"Int J Cancer"},{"key":"1958_CR4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00066-008-1842-2","volume":"184","author":"T. B\u00f6lling","year":"2008","unstructured":"B\u00f6lling T, K\u00f6nemann S, Ernst I, et al. Late effects of thoracic irradiation in children. Strahlenther Onkol 2008;184:289\u201395.","journal-title":"Strahlenther Onkol"},{"key":"1958_CR5","first-page":"1543","volume":"25","author":"F. Bruns","year":"2005","unstructured":"Bruns F, Raub M, Sch\u00e4fer U, et al. No predictive value of beta-HCG in patients with stage I seminoma - results of a long-term follow-up study after adjuvant radiotherapy. Anticancer Res 2005;25:1543\u20136.","journal-title":"Anticancer Res"},{"key":"1958_CR6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1126::AID-CNCR17>3.0.CO;2-8","volume":"82","author":"T.A. Buchholz","year":"1998","unstructured":"Buchholz TA, Walden TL, Prestidge BR. Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma. Cancer 1998;82:1126\u201333.","journal-title":"Cancer"},{"key":"1958_CR7","first-page":"66","volume":"22","author":"J. Classen","year":"1999","unstructured":"Classen J, Bamberg M. Gonadal toxicity and fertility after radiotherapy for testicular seminoma. Onkologie 1999;22:66\u20138.","journal-title":"Onkologie"},{"key":"1958_CR8","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/sj.bjc.6601867","volume":"90","author":"J. Classen","year":"2004","unstructured":"Classen J, Schmidberger H, Meisner C, et al. Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German Testicular Cancer Study Group (GTCSG). Br J Cancer 2004;90:2305\u201311.","journal-title":"Br J Cancer"},{"key":"1958_CR9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","volume":"17","author":"S.D. Fossa","year":"1999","unstructured":"Fossa SD, Horwich A, Russel JM, et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. J Clin Oncol 1999;17:1146\u201354.","journal-title":"J Clin Oncol"},{"key":"1958_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0360-3016(96)00597-4","volume":"38","author":"K.D. Jacobsen","year":"1997","unstructured":"Jacobsen KD, Olsen DR, Fossa K, et al. External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 1997;38:95\u2013102.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1958_CR11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","volume":"23","author":"W.G. Jones","year":"2005","unstructured":"Jones WG, Fossa SD, Mead GM, et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council trial TE18, European Organization for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 2005;23:1200\u20138.","journal-title":"J Clin Oncol"},{"key":"1958_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0360-3016(96)00093-4","volume":"35","author":"I.O. Kiricuta","year":"1996","unstructured":"Kiricuta IO, Sauer J, Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: a study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 1996;35:293\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1958_CR13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2007.12.024","volume":"53","author":"S. Krege","year":"2008","unstructured":"Krege S, Beyer J, Souchon S, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol 2008;53:478\u201396.","journal-title":"Eur Urol"},{"key":"1958_CR14","first-page":"296","volume":"13","author":"J.E. Livsey","year":"2001","unstructured":"Livsey JE, Taylor B, Mobarek N, et al. Patterns of relapse following radiotherapy for stage I seminoma of the testis: implications for follow-up. Clin Oncol 2001;13:296\u2013300.","journal-title":"Clin Oncol"},{"key":"1958_CR15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0360-3016(03)00754-5","volume":"57","author":"J.P. Logue","year":"2003","unstructured":"Logue JP, Harris MA, Livsey JE, et al. Short course para-aortic radiation for stage I seminoma of the testis. Int J Radiat Oncol Biol Phys 2003;57:1304\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1958_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00066-008-1793-7","volume":"184","author":"V. Ludwig","year":"2008","unstructured":"Ludwig V, Schwab F, Guckenberger M, et al. Comparison of wedge versus segmented techniques in whole breast irradiation. Effects on dose exposure outside the treatment volume. Strahlenther Onkol 2008;184:307\u201312.","journal-title":"Strahlenther Onkol"},{"key":"1958_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00066-007-1653-x","volume":"183","author":"M. Mazonakis","year":"2007","unstructured":"Mazonakis M, Zacharopoulou F, Kachris S, et al. Scattered dose to gonads and associated risks from radiotherapy for common pediatric malignancies. A phantom study. Strahlenther Onkol 2007;183:332\u20137.","journal-title":"A phantom study. Strahlenther Onkol"},{"key":"1958_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00066-007-1786-y","volume":"183","author":"A.C. M\u00fcller","year":"2007","unstructured":"M\u00fcller AC, Ganswindt U, Bamberg M, et al. Risk of second malignancies after prostate irradiation? Strahlenther Onkol 2007;183:605\u20139.","journal-title":"Strahlenther Onkol"},{"key":"1958_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/clon.2002.0194","volume":"15","author":"P.D. Nathan","year":"2003","unstructured":"Nathan PD, Rustin GR. The role of CT scanning in the surveillance of testicular tumours. Clin Oncol (R Coll Radiol) 2003;15:121\u20132.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1958_CR20","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1200\/JCO.1996.14.11.2933","volume":"14","author":"N.N. Sharda","year":"1996","unstructured":"Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: a cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14:2933\u20139.","journal-title":"J Clin Oncol"},{"key":"1958_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00345-004-0441-9","volume":"22","author":"J.R. Spermon","year":"2004","unstructured":"Spermon JR, Witjes JA, Kiemeney LALM. Efficacy of routine follow-up after first-line treatment for testicular cancer. World J Urol 2004;22:235\u201343.","journal-title":"World J Urol"},{"key":"1958_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0360-3016(97)00733-5","volume":"40","author":"K. Sultanem","year":"1998","unstructured":"Sultanem K, Souhami L, Benk V, et al. Para-aortic irradiation only appears to be adequate treatment for patients with stage I seminoma of the testis. Int J Radiat Oncol Biol Phys 1998;40:455\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1958_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","volume":"89","author":"L.B. Travis","year":"1997","unstructured":"Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429\u201339.","journal-title":"J Natl Cancer Inst"},{"key":"1958_CR24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","volume":"97","author":"L.B. Travis","year":"2005","unstructured":"Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 2005;97:1354\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"1958_CR25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<162::AID-CNCR22>3.0.CO;2-V","volume":"88","author":"M.J. Trigo","year":"2000","unstructured":"Trigo MJ, Tabernero JM, Paz-Ares L, et al. Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer 2000;88:162\u20138.","journal-title":"Cancer"},{"key":"1958_CR26","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","volume":"20","author":"P. Warde","year":"2002","unstructured":"Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 2002;20:4448\u201352.","journal-title":"J Clin Oncol"},{"key":"1958_CR27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000020055","volume":"36","author":"L. Weissbach","year":"1999","unstructured":"Weissbach L, Bussar-Maatz R, L\u00f6hrs U, et al. Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol 1999;36:601\u20138.","journal-title":"Eur Urol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1958-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-1958-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1958-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:30:54Z","timestamp":1558578654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-1958-z"}},"subtitle":["An analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patients"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1958"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-1958-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}